Obesity is an epidemic that has led to a rise in the incidence of many comorbidities: among others, reduced fertility is often under-evaluated in clinical practice. The mechanisms underlying the link between reduced fertility and obesity are numerous, with insulin resistance, hyperglycaemia and the frequent coexistence of polycystic ovary syndrome being the most acknowledged. However, several other factors concur, such as gut microbiome alterations, low-grade chronic inflammation and oxidative stress. Not only do women with obesity take longer to conceive, but in vitro fertilization (IVF) is also less likely to succeed. We herein provide an updated state-of-the-art regarding the molecular bases of what we could define as dysmetabolic infertility, focusing on the clinical aspects, as well as possible treatment.

Female infertility in the era of obesity. The clash of two pandemics or inevitable consequence? / Medenica, Sanja; Spoltore, Maria Elena; Ormazabal, Paulina; Marina, Ljiljana V; Sojat, Antoan Stefan; Faggiano, Antongiulio; Gnessi, Lucio; Mazzilli, Rossella; Watanabe, Mikiko. - In: CLINICAL ENDOCRINOLOGY. - ISSN 0300-0664. - 98:2(2022), pp. 141-152. [10.1111/cen.14785]

Female infertility in the era of obesity. The clash of two pandemics or inevitable consequence?

Medenica, Sanja;Spoltore, Maria Elena;Faggiano, Antongiulio;Gnessi, Lucio;Mazzilli, Rossella
;
Watanabe, Mikiko
Ultimo
2022

Abstract

Obesity is an epidemic that has led to a rise in the incidence of many comorbidities: among others, reduced fertility is often under-evaluated in clinical practice. The mechanisms underlying the link between reduced fertility and obesity are numerous, with insulin resistance, hyperglycaemia and the frequent coexistence of polycystic ovary syndrome being the most acknowledged. However, several other factors concur, such as gut microbiome alterations, low-grade chronic inflammation and oxidative stress. Not only do women with obesity take longer to conceive, but in vitro fertilization (IVF) is also less likely to succeed. We herein provide an updated state-of-the-art regarding the molecular bases of what we could define as dysmetabolic infertility, focusing on the clinical aspects, as well as possible treatment.
2022
assisted reproductive technology; body mass index; in vitro fertilization; miscarriage; overweight; polycystic ovary syndrome; pregnancy
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Female infertility in the era of obesity. The clash of two pandemics or inevitable consequence? / Medenica, Sanja; Spoltore, Maria Elena; Ormazabal, Paulina; Marina, Ljiljana V; Sojat, Antoan Stefan; Faggiano, Antongiulio; Gnessi, Lucio; Mazzilli, Rossella; Watanabe, Mikiko. - In: CLINICAL ENDOCRINOLOGY. - ISSN 0300-0664. - 98:2(2022), pp. 141-152. [10.1111/cen.14785]
File allegati a questo prodotto
File Dimensione Formato  
Medenica_Female-infertility-in the-era-of-obesity_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 665.88 kB
Formato Adobe PDF
665.88 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1643042
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 6
social impact